AI Medicine Could be First to Treat Disease With No Cure in a New Way
An AI-designed medicine for Inflammatory Bowel Disease enters Phase 1 clinical trials. Artificial Intelligence Biotech Company, Insilico Medicine, has reportedly entered the first phase of its clinical trials for the ISM5411.
United States Alex Zhavoronkov Aldohn Domingo Dana Farber Cancer Institute Under Scrutiny Allegations Of Research Misconduct Artificial Intelligence Biotech Company
Source: techtimes.com